{"count": 35, "results": [{"_id": "20089489", "pmid": 20089489, "title": "Randomized, double-blind, controlled study of losartan in children with proteinuria.", "journal": "Clin J Am Soc Nephrol", "authors": ["Webb NJ", "Lam C", "Loeys T", "Shahinfar S", "Strehlau J", "Wells TG", "Santoro E", "Manas D", "Gleim GW"], "date": "2010-03-01T00:00:00Z", "doi": "10.2215/CJN.06620909", "meta_date_publication": "2010 Mar", "meta_volume": "5", "meta_issue": "3", "meta_pages": "417-24", "score": 50073.562, "text_hl": "RESULTS: Twelve weeks of treatment with @CHEMICAL_Losartan @CHEMICAL_MESH:D019808 @@@losartan@@@ significantly reduced @<m>DISEASE_Proteinuria</m> @DISEASE_MESH:D011507 @@@proteinuria@@@ compared with @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@/placebo: @CHEMICAL_Losartan @CHEMICAL_MESH:D019808 @@@losartan@@@ -35.8% (95% confidence interval: -27.6% to -43.1%) versus @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@/placebo 1.4% (95% confidence interval: -10.3% to 14.5%), P < or = 0.001. ", "citations": {"NLM": "Webb NJ, Lam C, Loeys T, Shahinfar S, Strehlau J, Wells TG, Santoro E, Manas D, Gleim GW. Randomized, double-blind, controlled study of losartan in children with proteinuria. Clin J Am Soc Nephrol. 2010 Mar;5(3):417-24. PMID: 20089489", "BibTeX": "@article{20089489, title={Randomized, double-blind, controlled study of losartan in children with proteinuria.}, author={Webb NJ and Lam C and Loeys T and Shahinfar S and Strehlau J and Wells TG and Santoro E and Manas D and Gleim GW}, journal={Clin J Am Soc Nephrol}, volume={5}, number={3}, pages={417-24}}"}}, {"_id": "17785930", "pmid": 17785930, "title": "Efonidipine reduces proteinuria and plasma aldosterone in patients with chronic glomerulonephritis.", "journal": "Hypertens Res", "authors": ["Ishimitsu T", "Kameda T", "Akashiba A", "Takahashi T", "Ohta S", "Yoshii M", "Minami J", "Ono H", "Numabe A", "Matsuoka H"], "date": "2007-07-01T00:00:00Z", "doi": "10.1291/hypres.30.621", "meta_date_publication": "2007 Jul", "meta_volume": "30", "meta_issue": "7", "meta_pages": "621-6", "score": 50069.406, "text_hl": "The present study compared the @DISEASE_Chronic_Disease @DISEASE_MESH:D002908 @@@chronic@@@ effects of @CHEMICAL_efonidipine @CHEMICAL_MESH:C066425 @@@efonidipine@@@ and @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ on @<m>DISEASE_Proteinuria</m> @DISEASE_MESH:D011507 @@@proteinuria@@@ in @SPECIES_9606 @@@patients@@@ with @DISEASE_Glomerulonephritis @DISEASE_MESH:D005921 @@@chronic glomerulonephritis@@@. ", "citations": {"NLM": "Ishimitsu T, Kameda T, Akashiba A, Takahashi T, Ohta S, Yoshii M, Minami J, Ono H, Numabe A, Matsuoka H. Efonidipine reduces proteinuria and plasma aldosterone in patients with chronic glomerulonephritis. Hypertens Res. 2007 Jul;30(7):621-6. PMID: 17785930", "BibTeX": "@article{17785930, title={Efonidipine reduces proteinuria and plasma aldosterone in patients with chronic glomerulonephritis.}, author={Ishimitsu T and Kameda T and Akashiba A and Takahashi T and Ohta S and Yoshii M and Minami J and Ono H and Numabe A and Matsuoka H}, journal={Hypertens Res}, volume={30}, number={7}, pages={621-6}}"}}, {"_id": "20411599", "pmid": 20411599, "title": "Cilnidipine suppresses podocyte injury and proteinuria in metabolic syndrome rats: possible involvement of N-type calcium channel in podocyte.", "journal": "J Hypertens", "authors": ["Fan YY", "Kohno M", "Nakano D", "Ohsaki H", "Kobori H", "Suwarni D", "Ohashi N", "Hitomi H", "Asanuma K", "Noma T", "Tomino Y", "Fujita T", "Nishiyama A"], "date": "2010-05-01T00:00:00Z", "doi": "10.1097/hjh.0b013e328336ade3", "meta_date_publication": "2010 May", "meta_volume": "28", "meta_issue": "5", "meta_pages": "1034-43", "score": 50065.49, "text_hl": "@CHEMICAL_cilnidipine @CHEMICAL_MESH:C065927 @@@Cilnidipine@@@ suppressed the @<m>DISEASE_Proteinuria</m> @DISEASE_MESH:D011507 @@@proteinuria@@@ greater than @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ did. ", "citations": {"NLM": "Fan YY, Kohno M, Nakano D, Ohsaki H, Kobori H, Suwarni D, Ohashi N, Hitomi H, Asanuma K, Noma T, Tomino Y, Fujita T, Nishiyama A. Cilnidipine suppresses podocyte injury and proteinuria in metabolic syndrome rats: possible involvement of N-type calcium channel in podocyte. J Hypertens. 2010 May;28(5):1034-43. PMID: 20411599", "BibTeX": "@article{20411599, title={Cilnidipine suppresses podocyte injury and proteinuria in metabolic syndrome rats: possible involvement of N-type calcium channel in podocyte.}, author={Fan YY and Kohno M and Nakano D and Ohsaki H and Kobori H and Suwarni D and Ohashi N and Hitomi H and Asanuma K and Noma T and Tomino Y and Fujita T and Nishiyama A}, journal={J Hypertens}, volume={28}, number={5}, pages={1034-43}}"}}, {"_id": "15253102", "pmid": 15253102, "title": "Comparison between cilnidipine and amlodipine besilate with respect to proteinuria in hypertensive patients with renal diseases.", "journal": "Hypertens Res", "authors": ["Kojima S", "Shida M", "Yokoyama H"], "date": "2004-06-01T00:00:00Z", "doi": "10.1291/hypres.27.379", "meta_date_publication": "2004 Jun", "meta_volume": "27", "meta_issue": "6", "meta_pages": "379-85", "score": 50065.465, "text_hl": "This study compared @CHEMICAL_cilnidipine @CHEMICAL_MESH:C065927 @@@cilnidipine@@@ and @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ with respect to their effects on renal function and @<m>DISEASE_Proteinuria</m> @DISEASE_MESH:D011507 @@@proteinuria@@@. ", "citations": {"NLM": "Kojima S, Shida M, Yokoyama H. Comparison between cilnidipine and amlodipine besilate with respect to proteinuria in hypertensive patients with renal diseases. Hypertens Res. 2004 Jun;27(6):379-85. PMID: 15253102", "BibTeX": "@article{15253102, title={Comparison between cilnidipine and amlodipine besilate with respect to proteinuria in hypertensive patients with renal diseases.}, author={Kojima S and Shida M and Yokoyama H}, journal={Hypertens Res}, volume={27}, number={6}, pages={379-85}}"}}, {"_id": "12748343", "pmid": 12748343, "title": "Effect of losartan and amlodipine on proteinuria and transforming growth factor-beta1 in patients with IgA nephropathy.", "journal": "Nephrol Dial Transplant", "authors": ["Park HC", "Xu ZG", "Choi S", "Goo YS", "Kang SW", "Choi KH", "Ha SK", "Lee HY", "Han DS"], "date": "2003-06-01T00:00:00Z", "doi": "10.1093/ndt/gfg090", "meta_date_publication": "2003 Jun", "meta_volume": "18", "meta_issue": "6", "meta_pages": "1115-21", "score": 50063.746, "text_hl": "Effect of @CHEMICAL_Losartan @CHEMICAL_MESH:D019808 @@@losartan@@@ and @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ on @<m>DISEASE_Proteinuria</m> @DISEASE_MESH:D011507 @@@proteinuria@@@ and @GENE_TGFB1 @GENE_7040 @@@transforming growth factor-beta1@@@ in @SPECIES_9606 @@@patients@@@ with @DISEASE_Glomerulonephritis_IGA @DISEASE_MESH:D005922 @@@IgA nephropathy@@@.", "citations": {"NLM": "Park HC, Xu ZG, Choi S, Goo YS, Kang SW, Choi KH, Ha SK, Lee HY, Han DS. Effect of losartan and amlodipine on proteinuria and transforming growth factor-beta1 in patients with IgA nephropathy. Nephrol Dial Transplant. 2003 Jun;18(6):1115-21. PMID: 12748343", "BibTeX": "@article{12748343, title={Effect of losartan and amlodipine on proteinuria and transforming growth factor-beta1 in patients with IgA nephropathy.}, author={Park HC and Xu ZG and Choi S and Goo YS and Kang SW and Choi KH and Ha SK and Lee HY and Han DS}, journal={Nephrol Dial Transplant}, volume={18}, number={6}, pages={1115-21}}"}}, {"_id": "15295613", "pmid": 15295613, "title": "Beneficial action of candesartan cilexetil plus amlodipine or ACE inhibitors in chronic nondiabetic renal disease.", "journal": "J Hum Hypertens", "authors": ["Homma K", "Hayashi K", "Kanda T", "Yoshioka K", "Takamatsu I", "Tatematsu S", "Kumagai H", "Wakino S", "Saruta T"], "date": "2004-12-01T00:00:00Z", "doi": "10.1038/sj.jhh.1001761", "meta_date_publication": "2004 Dec", "meta_volume": "18", "meta_issue": "12", "meta_pages": "879-84", "score": 50062.094, "text_hl": "Of note, the @<m>DISEASE_Proteinuria</m> @DISEASE_MESH:D011507 @@@proteinuria@@@-sparing effect did not differ between the @CHEMICAL_candesartan @CHEMICAL_MESH:C081643 @@@candesartan@@@+ACEI group and the @CHEMICAL_candesartan @CHEMICAL_MESH:C081643 @@@candesartan@@@+@<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ group. ", "citations": {"NLM": "Homma K, Hayashi K, Kanda T, Yoshioka K, Takamatsu I, Tatematsu S, Kumagai H, Wakino S, Saruta T. Beneficial action of candesartan cilexetil plus amlodipine or ACE inhibitors in chronic nondiabetic renal disease. J Hum Hypertens. 2004 Dec;18(12):879-84. PMID: 15295613", "BibTeX": "@article{15295613, title={Beneficial action of candesartan cilexetil plus amlodipine or ACE inhibitors in chronic nondiabetic renal disease.}, author={Homma K and Hayashi K and Kanda T and Yoshioka K and Takamatsu I and Tatematsu S and Kumagai H and Wakino S and Saruta T}, journal={J Hum Hypertens}, volume={18}, number={12}, pages={879-84}}"}}, {"_id": "30026623", "pmid": 30026623, "title": "Successful management of proteinuria and systemic hypertension in a dog with renal cell carcinoma with surgery, telmisartan, and amlodipine.", "journal": "Can Vet J", "authors": ["Kwon YJ", "Suh GH", "Kang SS", "Kim HJ"], "date": "2018-07-01T00:00:00Z", "meta_date_publication": "2018 Jul", "meta_volume": "59", "meta_issue": "7", "meta_pages": "759-762", "score": 50061.555, "text_hl": "Successful management of @<m>DISEASE_Proteinuria</m> @DISEASE_MESH:D011507 @@@proteinuria@@@ and systemic @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ in a @SPECIES_9615 @@@dog@@@ with @DISEASE_Carcinoma_Renal_Cell @DISEASE_MESH:D002292 @@@renal cell carcinoma@@@ with surgery, @CHEMICAL_Telmisartan @CHEMICAL_MESH:D000077333 @@@telmisartan@@@, and @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@.", "citations": {"NLM": "Kwon YJ, Suh GH, Kang SS, Kim HJ. Successful management of proteinuria and systemic hypertension in a dog with renal cell carcinoma with surgery, telmisartan, and amlodipine. Can Vet J. 2018 Jul;59(7):759-762. PMID: 30026623", "BibTeX": "@article{30026623, title={Successful management of proteinuria and systemic hypertension in a dog with renal cell carcinoma with surgery, telmisartan, and amlodipine.}, author={Kwon YJ and Suh GH and Kang SS and Kim HJ}, journal={Can Vet J}, volume={59}, number={7}, pages={759-762}}"}}, {"_id": "20828221", "pmid": 20828221, "title": "Antiproteinuric effect of cilnidipine in hypertensive Japanese treated with renin-angiotensin-system inhibitors - a multicenter, open, randomized trial using 24-hour urine collection.", "journal": "Clin Exp Hypertens", "authors": ["Miwa Y", "Tsuchihashi T", "Ohta Y", "Tominaga M", "Kawano Y", "Sasaguri T", "Ueno M", "Matsuoka H"], "date": "2010-01-01T00:00:00Z", "doi": "10.3109/10641961003667914", "meta_date_publication": "2010", "meta_volume": "32", "meta_issue": "6", "meta_pages": "400-5", "score": 50061.043, "text_hl": "Our findings suggest that @CHEMICAL_cilnidipine @CHEMICAL_MESH:C065927 @@@cilnidipine@@@ is superior to @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ in preventing the progression of @<m>DISEASE_Proteinuria</m> @DISEASE_MESH:D011507 @@@proteinuria@@@ in @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertensive@@@ @SPECIES_9606 @@@patients@@@ even undergoing treatment with RAS inhibitors.", "citations": {"NLM": "Miwa Y, Tsuchihashi T, Ohta Y, Tominaga M, Kawano Y, Sasaguri T, Ueno M, Matsuoka H. Antiproteinuric effect of cilnidipine in hypertensive Japanese treated with renin-angiotensin-system inhibitors - a multicenter, open, randomized trial using 24-hour urine collection. Clin Exp Hypertens. 2010;32(6):400-5. PMID: 20828221", "BibTeX": "@article{20828221, title={Antiproteinuric effect of cilnidipine in hypertensive Japanese treated with renin-angiotensin-system inhibitors - a multicenter, open, randomized trial using 24-hour urine collection.}, author={Miwa Y and Tsuchihashi T and Ohta Y and Tominaga M and Kawano Y and Sasaguri T and Ueno M and Matsuoka H}, journal={Clin Exp Hypertens}, volume={32}, number={6}, pages={400-5}}"}}, {"_id": "22739977", "pmid": 22739977, "title": "Losartan and enalapril are comparable in reducing proteinuria in children.", "journal": "Kidney Int", "authors": ["Webb NJ", "Shahinfar S", "Wells TG", "Massaad R", "Gleim GW", "Santoro EP", "Sisk CM", "Lam C"], "date": "2012-10-01T00:00:00Z", "doi": "10.1038/ki.2012.210", "meta_date_publication": "2012 Oct", "meta_volume": "82", "meta_issue": "7", "meta_pages": "819-26", "score": 50059.37, "text_hl": "Here we assessed an open-label extension of a previous 3-month blinded trial, in which the efficacy and tolerability of @CHEMICAL_Losartan @CHEMICAL_MESH:D019808 @@@losartan@@@ was compared to placebo or @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ in 306 normotensive and @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertensive@@@ children with @<m>DISEASE_Proteinuria</m> @DISEASE_MESH:D011507 @@@proteinuria@@@. ", "citations": {"NLM": "Webb NJ, Shahinfar S, Wells TG, Massaad R, Gleim GW, Santoro EP, Sisk CM, Lam C. Losartan and enalapril are comparable in reducing proteinuria in children. Kidney Int. 2012 Oct;82(7):819-26. PMID: 22739977", "BibTeX": "@article{22739977, title={Losartan and enalapril are comparable in reducing proteinuria in children.}, author={Webb NJ and Shahinfar S and Wells TG and Massaad R and Gleim GW and Santoro EP and Sisk CM and Lam C}, journal={Kidney Int}, volume={82}, number={7}, pages={819-26}}"}}, {"_id": "11281338", "pmid": 11281338, "title": "Verapamil versus amlodipine in proteinuric non-diabetic nephropathies treated with trandolapril (VVANNTT study): design of a prospective randomized multicenter trial.", "journal": "J Nephrol", "authors": ["Boero R", "Rollino C", "Massara C", "Vagelli G", "Gonella M", "Berto IM", "Bajardi P", "Perosa P", "Malcangi U", "Giorgi MP", "Ghezzi PM", "Borzumati M", "Baroni AM", "Cogno C", "Triolo G", "Angelini D", "Antonelli A", "Quarello F"], "date": "2001-01-01T00:00:00Z", "meta_date_publication": "2001 Jan-Feb", "meta_volume": "14", "meta_issue": "1", "meta_pages": "15-8", "score": 50057.195, "text_hl": "@CHEMICAL_Verapamil @CHEMICAL_MESH:D014700 @@@Verapamil@@@ versus @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ in @<m>DISEASE_Proteinuria</m> @DISEASE_MESH:D011507 @@@proteinuric@@@ non-@DISEASE_Diabetic_Nephropathies @DISEASE_MESH:D003928 @@@diabetic nephropathies@@@ treated with @CHEMICAL_trandolapril @CHEMICAL_MESH:C052035 @@@trandolapril@@@ (VVANNTT study): design of a prospective randomized multicenter trial.", "citations": {"NLM": "Boero R, Rollino C, Massara C, Vagelli G, Gonella M, Berto IM, Bajardi P, Perosa P, Malcangi U, Giorgi MP, Ghezzi PM, Borzumati M, Baroni AM, Cogno C, Triolo G, Angelini D, Antonelli A, Quarello F. Verapamil versus amlodipine in proteinuric non-diabetic nephropathies treated with trandolapril (VVANNTT study): design of a prospective randomized multicenter trial. J Nephrol. 2001 Jan-Feb;14(1):15-8. PMID: 11281338", "BibTeX": "@article{11281338, title={Verapamil versus amlodipine in proteinuric non-diabetic nephropathies treated with trandolapril (VVANNTT study): design of a prospective randomized multicenter trial.}, author={Boero R and Rollino C and Massara C and Vagelli G and Gonella M and Berto IM and Bajardi P and Perosa P and Malcangi U and Giorgi MP and Ghezzi PM and Borzumati M and Baroni AM and Cogno C and Triolo G and Angelini D and Antonelli A and Quarello F}, journal={J Nephrol}, volume={14}, number={1}, pages={15-8}}"}}]}